Tecnimede
Private Company
Total funding raised: $30M
Overview
Tecnimede is a well-established, private Portuguese pharmaceutical player with a core business in generic drugs. It has built integrated capabilities spanning development, manufacturing, and marketing, primarily serving the Iberian and international markets. The company's strategy involves leveraging its generic foundation to support a growing portfolio of value-added medicines and innovative healthcare solutions. Its longevity and vertical integration position it as a significant contributor to pharmaceutical access in its operating regions.
Technology Platform
Integrated pharmaceutical development and manufacturing platform focused on generic drug formulation, bioequivalence, and GMP production, with capabilities extending to innovative drug delivery and value-added medicines.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Operates in the highly competitive global generic pharmaceutical sector, competing with large multinational generics firms (e.g., Teva, Sandoz) and regional players. In Portugal and Spain, it faces competition from other Iberian generics manufacturers and subsidiaries of international groups. Differentiation is sought through integrated operations, niche products, and innovative formulations.